Filing Flows › Orthofix Medical (OFIX) › Q1 FY26 › vs Q4 FY25
Orthofix Medical (OFIX) Q1 FY26 vs Q4 FY25 (quarter over quarter)
Orthofix Medical's revenue fell $23.2M (-11%) from $220M in Q4 FY25 to $197M in Q1 FY26.
Orthofix Medical, Q1 FY26: revenue $197M (+2% year over year), operating margin -7.3%, net loss $20.9M, operating cash flow −$17.6M. The chart draws each line against Q4 FY25, the increases inside each band.
Every line
| Line | Q1 FY26 | Q4 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $197M | $220M | −$23.2M | -11% |
| Net loss | $20.9M | $2.2M | $18.7M | +841% |
| Costs & expenses | $218M | $222M | −$4.5M | -2% |
| Operating costs | $211M | $219M | −$8.3M | -4% |
| Interest & other, net | $6.4M | $2.7M | $3.7M | +138% |
| Income tax | $74K | $30K | $44K | +147% |
| Cost of revenue | $57.2M | $63.6M | −$6.4M | -10% |
| Research & development | $15.3M | $15.4M | −$53K | -0.3% |
| SG&A | $135M | $137M | −$1.8M | -1% |
| Other operating costs | $3.8M | $3.7M | $29K | +0.8% |
| Operating cash sources | $37.6M | −$7.4M | $45.0M | — |
| Depreciation & amortization | $13.5M | $13.1M | $415K | +3% |
| Share-based compensation | $6.5M | $7.2M | −$681K | -9% |
| Cash used in operations | $17.6M | −$27.7M | $45.3M | — |
| Net loss absorbed | $20.9M | $2.2M | $18.7M | +841% |
| Working capital & other | $16.7M | −$9.6M | $26.4M | — |
Questions
How much did Orthofix Medical's revenue grow quarter over quarter in Q1 FY26?
Orthofix Medical's revenue fell $23.2M (-11%) from $220M in Q4 FY25 to $197M in Q1 FY26.